Diligence memo · auto-generated · as of July 3, 2026

Philadelphia Urgent Care Management, Inc.

Philadelphia Urgent Care Management, Inc. looks over-valued against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

Philadelphia Urgent Care Management, Inc. operates in Business Services, based in Bala Cynwyd.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Philadelphia Urgent Care Management, Inc. has raised $29M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $12M on 2018-05-09.

Most recent recorded round closed around 2023-07-07.

Valuation (modeled)modeled

Provath models Philadelphia Urgent Care Management, Inc. at approximately $65M (range $12M–$175M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.57× the median modeled value of Series A Business Services companies in 2022–2024 (68 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 21 months.

Last raise 3.0 yr ago; this sector typically re-raises about every 12 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round stepped up 3.6× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 92% of Business Services peers (2439 compared).

Modeled value ranks above 82% of those peers.

Closest niche peers: GrayMeta, Inc., Klick Ventures Inc., Roo Veterinary, Inc., RK Logistics Holdings Inc., Semify Holdings, LLC.

Peoplefiled

10 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.